RHAPSODY Final Consortium meeting

Today starts our final consortium meeting, a two days hybrid meeting concluding 5 incredible years with amazing results. To learn more you can still register to our Final Symposium, next Friday free & everyone is welcome.


A new model for studies of beta-cell function

The TUD researchers contributed to overcome translational gap by developing novel in-vivo model for the labeling of insulin secretory granule pools.

Read the full article.

RHAPSODY Final Symposium

In the end of the project, the RHAPSODY team is eager to share its achievements with patient and healthcare communities and welcomes all to a public half-day symposium on September 17, 2021.
Registration is now open
.

Joined RHAPSODY publication in Diabetologia

Just published in Diabetologia, a new joined study by the RHAPSODY consortium on T2D subtypes clusters: "Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study"

Read it here.

Registration Open ! IMI impact on diabetes Virtual Event

As part of the first round of IMI Impact Series virtual events, registration are opening today for the  DIABETES session that will take place on 8th June 2021 from 3pm to 5pm CET.

Show more posts

Stacks Image 47
Stacks Image 398
Stacks Image 51
Stacks Image 349
This project receives funding from the Innovative Medicines Initiative 2 Joint Undertaking (www.imi.europa.eu) under grant agreement No 115881. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

This work is supported by the Swiss State Secretariat for Education‚ Research and Innovation (SERI) under contract number 16.0097-2.

The opinions expressed and arguments employed herein do not necessarily reflect the official views of these funding bodies.